4d pharma analyst ratings
4d pharma analyst ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 06/27/2022 | — | Chardan Capital | Downgrades | Buy → Neutral | |
| 05/13/2021 | 2021.21% | Ladenburg Thalmann | → $35 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 06/27/2022 | — | 查爾丹資本 | 評級下調 | 購買→中性 | |
| 05/13/2021 | 2021.21% | 拉登堡·塔爾曼 | → $35 | 開始承保 | →購買 |
4d pharma Questions & Answers
4D藥學問答
The latest price target for 4d pharma (NASDAQ: LBPS) was reported by Chardan Capital on June 27, 2022. The analyst firm set a price target for $0.00 expecting LBPS to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
查爾丹資本於2022年6月27日報道了4D製藥公司(納斯達克代碼：LBPS)的最新目標價。這家分析公司將目標價定為0.00美元，預計LBPS將在12個月內降至(可能下跌-100.00%)。1家分析公司在過去一年公佈了評級。
The latest analyst rating for 4d pharma (NASDAQ: LBPS) was provided by Chardan Capital, and 4d pharma downgraded their neutral rating.
分析師對4D製藥公司(納斯達克代碼：LBPS)的最新評級由查爾丹資本提供，4D製藥公司下調了其中性評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of 4d pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for 4d pharma was filed on June 27, 2022 so you should expect the next rating to be made available sometime around June 27, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閲公共財務報表，與4d製藥公司的高管和客户交談，以及收聽財報電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。4D製藥的上一次評級是在2022年6月27日提交的，所以你應該預計下一次評級將在2023年6月27日左右的某個時候公佈。
While ratings are subjective and will change, the latest 4d pharma (LBPS) rating was a downgraded with a price target of $0.00 to $0.00. The current price 4d pharma (LBPS) is trading at is $1.65, which is out of the analyst's predicted range.
雖然評級是主觀的，而且會發生變化，但最新的4D製藥(LBPS)評級被下調，目標價從0.00美元降至0.00美元。目前4D Pharma的交易價格為1.65美元，超出了分析師的預期區間。